LACTOFERRIN SCAN^®

T5009 / 30351

A quantitative ELISA for the detection of fecal lactoferrin.

The LACTOFERRIN SCAN^® test is a quantitative ELISA for measuring concentrations of fecal lactoferrin, a marker of fecal leukocytes. An elevated level is an indicator of intestinal inflammation.

The test can be used as an in vitro diagnostic aid to distinguish patients with active inflammatory bowel disease (IBD) from those with non-inflammatory irritable bowel syndrome (IBS). In addition, the test can be used to assess when an IBD patient is in confirmed remission and has responded to treatment.

Quantitative assay to determine the concentration of fecal lactoferrin present to guide treatment decisions
Prediluted standards
Accurate measurement of both solid and liquid fecal samples using novel pipette design
Noninvasive
Automatable

TL_INFLAMM_LF_SCAN_9644_completed

Quantitative assay to determine the presence of intestinal inflammation

Prediluted standards

Accurate measurement of both solid and liquid fecal samples

Documentation

Package Insert – US Version (PDF) Issued 07/2021
Package Insert – International Version (PDF) Issued 03/2023
CPT Codes – Issued 02/2023

LACTOFERRIN SCAN^® Publications and Poster Presentations

Ribotype 027 is Associated with Increased Lactoferrin and Toxin in Patients with Clinically Defined C. difficile Disease
American Society of Microbiology meeting, May 2011, New Orleans, LA

Evaluation of Fecal Lactoferrin, CRP and Clinical Activity Indices for Assessing the Presence of Intestinal Inflammation in IBD and IBS Patients Classified by Ileocolonoscopy

Comparison of CRP, Clinical Activity Indices and Fecal Lactoferrin with Disease Status in Ileocolonoscopy of Patients with IBD and IBS
Digestive Disease Week, May 2006, Los Angeles, CA

A Comparison Among Four Neutrophil-Derived Proteins in Feces as Indicator of Disease Activity in Ulcerative Colitis
Digestive Disease Week, May 2004, New Orleans, LA

Serial Fecal Lactoferrin Measurements are Useful in the Interval Assessment of Patients with Active and Inactive Inflammatory Bowel Disease
Digestive Disease Week, May 2004, New Orleans, LA

Fecal Lactoferrin: Sensitive Marker for Monitoring Pediatric Patients with Inflammatory Bowel Disease (IBD)
Digestive Disease Week, May 2003, Orlando, FL